Aprepitant

FDA Approved: * September 24, 2012
Pharm Company: * SANDOZ
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Aprepitant Overview

Aprepitant (brand name: Emend (the brand name used in all English-speaking countries)) is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor. Aprepitant is manufactured by Merck & Co. under the brand name Emend for prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) and for prevention of postoperative nausea and vomiting. It was approved by th...

Read more Aprepitant Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aprepitant

Recent Aprepitant Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Aprepitant: (8 results)

Sorted by National Drug Code

• 0781-2321 Aprepitant 40 mg Oral Capsule by Sandoz Inc
• 0781-2322 Aprepitant 80 mg Oral Capsule by Sandoz Inc
• 0781-2323 Aprepitant 125 mg Oral Capsule by Sandoz Inc
• 0781-4063 Aprepitant Kit by Sandoz Inc
• 68462-112 Aprepitant Kit by Glenmark Pharmaceuticals Inc., USA
• 68462-583 Aprepitant 40 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA
• 68462-584 Aprepitant 80 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA
• 68462-585 Aprepitant 125 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA

Other drugs which contain Aprepitant or a similar ingredient: (2 results)

• CINVANTI Aprepitant
• EMEND Aprepitant1 discussion

Related Aprepitant Topics: